Arbutus Biopharma Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hello, everyone. Thanks for joining us today. My name is Emily Bodnar and I'm an associate here at Cantor Fitzgerald. I'm happy to introduce Bill Collier, who is the President and CEO of Arbutus Biopharma. We will be doing a formal presentation. And with that, I will pass it off to Bill to begin.
Thank you very much. Good morning and welcome, everybody. Thank you for your interest and your time today. These are our forward-looking statements, and these can be found on our Company website, www.arbutusbio.com. And by way of introduction to Arbutus, I would like to highlight a couple of key points. One is we are a company that is focused on chronic hepatitis B infection. And we are focused on this because it is a significant unmet medical need with a global prevalence probably double that of hepatitis C. So the potential for a very large market.
And our aim is to find a functional
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |